The association between SPINK1 and clinical outcomes in patients with prostate cancer: a systematic review and meta-analysis

Evidence of the prognostic role of serine peptidase inhibitor Kazal type 1 (SPINK1) in prostate cancer (PCa) is controversial. The aim of this study was, therefore, to evaluate the association between SPINK1 and clinical outcomes in PCa. Searches were made of PubMed, Medline, Embase, and the China B...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Onco Targets Ther
Hauptverfasser: Zhang, Xingming, Yin, Xiaoxue, Shen, Pengfei, Sun, Guangxi, Yang, Yaojing, Liu, Jiandong, Chen, Ni, Zeng, Hao
Format: Artigo
Sprache:Inglês
Veröffentlicht: Dove Medical Press 2017
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5488756/
https://ncbi.nlm.nih.gov/pubmed/28790846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S127317
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge